Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin

Journal of Thrombosis and Thrombolysis

Volumn 34, Issue 1, 2012, Pages 114-119

  Thomas, Michael P ^a,h   Mahaffey, Kenneth W ^a   Chiswell, Karen ^a   Cohen, Marc ^b   Kontos, Michael C ^c   Antman, Elliott M ^d   Ferguson, James J ^e   Califf, Robert M ^f   Goodman, Shaun G ^g   Becker, Richard C ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e ASTRAZENECA   (United Kingdom)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Activated partial thromboplastin time; Bleeding; Non ST segment elevation acute coronary syndromes; Unfractionated heparin

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULATION; ARTICLE; BLEEDING DISORDER; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DRUG DOSE TITRATION; DRUG FATALITY; EARLY DIAGNOSIS; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PARTIAL THROMBOPLASTIN TIME; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; ST SEGMENT DEPRESSION; STROKE; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84863420642     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0693-y     Document Type: Article

References (11)

1. Anderson JL, Adams CD, Antman EM et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons; endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50:e1-e157
2. SS Anand S Yusuf J Pogue, et al. 2003 Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin Circulation 107 2884 2888 12796128 10.1161/01.CIR.0000077530.53367.E9
3. IC Gilchrist SD Berkowitz TD Thompson, et al. 2002 Heparin dosing and outcome in acute coronary syndromes: the GUSTO-IIb experience Am Heart J 144 73 80 12094191 10.1067/mhj.2002.123112 1:CAS:528:DC%2BD38XlvFyqs7Y%3D
4. CB Granger J Hirsh RM Califf, et al. 1996 Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction. Results from the GUSTO-I trial Circulation 93 870 878 8598077 10.1161/01.CIR.93.5.870 1:CAS:528:DyaK28XitVGntbw%3D
5. SYNERGY Executive Committee 2002 The SYNERGY trial: study design and rational Am Heart J 143 952 960 10.1067/mhj.2002.122120
6. JJ Ferguson RM Califf EM Antman, et al. 2004 Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation in acute coronary syndromes managed with an intended early invasive strategy JAMA 292 45 54 15238590 10.1001/jama.292.1.45 1:CAS:528:DC%2BD2cXls1elsrg%3D
7. Braunwald E, Antman EM, Beasley JW et al (2002) ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on the Management of Patients With Unstable Angina). Circulation 106:1893-1900
8. S Yusuf F Zhao SR Mehta, et al. 2001 Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 494 502 11519503 10.1056/NEJMoa010746 1:CAS:528:DC%2BD3MXms1arsrY%3D
9. KP Alexander AY Chen MT Roe, et al. 2005 Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes JAMA 294 3108 3116 16380591 10.1001/jama.294.24.3108 1:CAS:528:DC%2BD28Xmtl2l
10. S Cheng DA Morrow S Sloan, et al. 2009 Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction Circulation 119 1195 1202 19237657 10.1161/CIRCULATIONAHA.108.814996 1:CAS:528:DC%2BD1MXisFCjs70%3D
11. KW Mahaffey SG Goodman 2006 Low-molecular-weight heparin vs unfractionated heparin in acute coronary syndromes-reply JAMA 295 2353 2354 10.1001/jama.295.20.2353-b 1:CAS:528:DC%2BD28Xlt1Gjs70%3D